Cargando…

Kv1.1 Channelopathies: Pathophysiological Mechanisms and Therapeutic Approaches

Kv1.1 belongs to the Shaker subfamily of voltage-gated potassium channels and acts as a critical regulator of neuronal excitability in the central and peripheral nervous systems. KCNA1 is the only gene that has been associated with episodic ataxia type 1 (EA1), an autosomal dominant disorder charact...

Descripción completa

Detalles Bibliográficos
Autores principales:	D’Adamo, Maria Cristina, Liantonio, Antonella, Rolland, Jean-Francois, Pessia, Mauro, Imbrici, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215777/ https://www.ncbi.nlm.nih.gov/pubmed/32331416 http://dx.doi.org/10.3390/ijms21082935

Ejemplares similares

Commentary: A channelopathy mutation in the voltage-sensor discloses contributions of a conserved phenylalanine to gating properties of Kv1.1 channels and ataxia
por: Hasan, Sonia, et al.
Publicado: (2018)

A channelopathy mutation in the voltage-sensor discloses contributions of a conserved phenylalanine to gating properties of Kv1.1 channels and ataxia
por: Hasan, Sonia, et al.
Publicado: (2017)

Kv1.1 knock-in ataxic mice exhibit spontaneous myokymic activity exacerbated by fatigue, ischemia and low temperature
por: Brunetti, Orazio, et al.
Publicado: (2012)

Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery
por: Imbrici, Paola, et al.
Publicado: (2016)

Novel phenotype associated with a mutation in the KCNA1(Kv1.1) gene
por: D'Adamo, Maria C., et al.
Publicado: (2015)

Clinical and Functional Study of a De Novo Variant in the PVP Motif of Kv1.1 Channel Associated with Epilepsy, Developmental Delay and Ataxia
por: Dinoi, Giorgia, et al.
Publicado: (2022)

An activator of voltage-gated K(+) channels Kv1.1 as a therapeutic candidate for episodic ataxia type 1
por: Servettini, Ilenio, et al.
Publicado: (2023)

Brugada Syndrome: More than a Monogenic Channelopathy
por: Liantonio, Antonella, et al.
Publicado: (2023)

Musculoskeletal Features without Ataxia Associated with a Novel de novo Mutation in KCNA1 Impairing the Voltage Sensitivity of Kv1.1 Channel
por: Imbrici, Paola, et al.
Publicado: (2021)

Kcnj16 (Kir5.1) Gene Ablation Causes Subfertility and Increases the Prevalence of Morphologically Abnormal Spermatozoa
por: Poli, Giulia, et al.
Publicado: (2021)

A Novel KCNA2 Variant in a Patient with Non-Progressive Congenital Ataxia and Epilepsy: Functional Characterization and Sensitivity to 4-Aminopyridine
por: Imbrici, Paola, et al.
Publicado: (2021)

Locus Coeruleus Neurons’ Firing Pattern Is Regulated by ERG Voltage-Gated K(+) Channels
por: Hasan, Sonia, et al.
Publicado: (2022)

ClC-1 chloride channels: state-of-the-art research and future challenges
por: Imbrici, Paola, et al.
Publicado: (2015)

Skeletal muscle Ca(V)1.1 channelopathies
por: Flucher, Bernhard E.
Publicado: (2020)

Pathophysiological Role of Omega Pore Current in Channelopathies
por: Jurkat-Rott, Karin, et al.
Publicado: (2012)

Small Molecules Targeting Kidney ClC-K Chloride Channels: Applications in Rare Tubulopathies and Common Cardiovascular Diseases
por: Coppola, Maria Antonietta, et al.
Publicado: (2023)

Identification of a New de Novo Mutation Underlying Regressive Episodic Ataxia Type I
por: Karalok, Zeynep S., et al.
Publicado: (2018)

Alteration of STIM1/Orai1-Mediated SOCE in Skeletal Muscle: Impact in Genetic Muscle Diseases and Beyond
por: Conte, Elena, et al.
Publicado: (2021)

Kv3.1 channelopathy: a novel loss-of-function variant and the mechanistic basis of its clinical phenotypes
por: Li, Xiaoyang, et al.
Publicado: (2021)

Sarcoplasmic Reticulum Ca(2+) Buffer Proteins: A Focus on the Yet-To-Be-Explored Role of Sarcalumenin in Skeletal Muscle Health and Disease
por: Conte, Elena, et al.
Publicado: (2023)

I–J loop involvement in the pharmacological profile of CLC-K channels expressed in Xenopus oocytes
por: Gradogna, Antonella, et al.
Publicado: (2014)

K(+) channelepsy: progress in the neurobiology of potassium channels and epilepsy
por: D'Adamo, Maria Cristina, et al.
Publicado: (2013)

Biophysical Aspects of Neurodegenerative and Neurodevelopmental Disorders Involving Endo-/Lysosomal CLC Cl(−)/H(+) Antiporters
por: Coppola, Maria Antonietta, et al.
Publicado: (2023)

KCNMA1-linked channelopathy
por: Bailey, Cole S., et al.
Publicado: (2019)

Type 2 Diabetes in Youth: Epidemiology and Pathophysiology
por: D’Adamo, Ebe, et al.
Publicado: (2011)

α-Synuclein–induced Kv4 channelopathy in mouse vagal motoneurons drives nonmotor parkinsonian symptoms
por: Chiu, Wei-Hua, et al.
Publicado: (2021)

Channelopathies
por: Kim, June-Bum
Publicado: (2014)

Multidisciplinary study of a new ClC-1 mutation causing myotonia congenita: a paradigm to understand and treat ion channelopathies
por: Imbrici, Paola, et al.
Publicado: (2016)

Erratum: K(+) channelepsy: progress in the neurobiology of potassium channels and epilepsy
por: D'Adamo, Maria C., et al.
Publicado: (2014)

Identification of Selective Inhibitors of the Potassium Channel Kv1.1–1.2((3)) by High-Throughput Virtual Screening and Automated Patch Clamp
por: Wacker, Sören J, et al.
Publicado: (2012)

Gain-of-Function STIM1 L96V Mutation Causes Myogenesis Alteration in Muscle Cells From a Patient Affected by Tubular Aggregate Myopathy
por: Conte, Elena, et al.
Publicado: (2021)

The role of ion channels in the hypoxia-induced aggressiveness of glioblastoma
por: Sforna, Luigi, et al.
Publicado: (2015)

Update on the implication of potassium channels in autism: K(+) channelautism spectrum disorder
por: Guglielmi, Luca, et al.
Publicado: (2015)

Oligomerization and Spatial Distribution of Kvβ1.1 and Kvβ2.1 Regulatory Subunits
por: Roig, Sara R., et al.
Publicado: (2022)

Muscle channelopathies and electrophysiological approach
por: Cherian, Ajith, et al.
Publicado: (2008)

Kv1.1 channel subunits in the control of neurocardiac function
por: Glasscock, Edward
Publicado: (2019)

Kv7 and Kv11 channels in myometrial regulation
por: Greenwood, Iain A, et al.
Publicado: (2014)

Reconciling the discrepancies on the involvement of large-conductance Ca(2+)-activated K channels in glioblastoma cell migration
por: Catacuzzeno, Luigi, et al.
Publicado: (2015)

Dexamethasone in Glioblastoma Multiforme Therapy: Mechanisms and Controversies
por: Cenciarini, Marta, et al.
Publicado: (2019)

Pathophysiology of Cystic Fibrosis Liver Disease: A Channelopathy Leading to Alterations in Innate Immunity and in Microbiota
por: Fiorotto, Romina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vc9p1olfadgmv07knnil1u31ah